AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32419038 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical resection with margin-negative resection and regional lymphadenectomy
Number of subjects: 0
Study 32419038 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant therapy strategies
Number of subjects: 0
Study 35293844 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute exercise (high-intensity, low-intensity, moderate-intensity, treadmill jogging, cycling, racquetball)
Number of subjects: 0
Study 35293844 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute exercise
Number of subjects: 0
Study 35293844 — intervention group
Group type: EXPERIMENTAL
Intervention: Select exercise modalities (e.g. treadmill exercise)
Number of subjects: 0
Study 34349379 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl patch 25 μg·h‐1
Number of subjects: 150
Study 34349379 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine patch 10 μg·h‐1
Number of subjects: 150
Study 34349379 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine patch 20 μg·h‐1
Number of subjects: 150
Study 35921797 — intervention group
Group type: EXPERIMENTAL
Intervention: Reshaping group (closure of excision defect with mobilised breast tissue)
Number of subjects: 233
Study 35921797 — intervention group
Group type: COMPARATOR
Intervention: Control group (no attempt at defect closure)
Number of subjects: 233
Study 34472600 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's sleep quality during COVID-19 pandemic
Number of subjects: 85
Study 34472600 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors contributing to sleep changes
Number of subjects: 85
Study 34472600 — intervention group
Group type: EXPERIMENTAL
Intervention: Disrupted routines
Number of subjects: 85
Study 34472600 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth interventions (BNBD)
Number of subjects: 85
Study 35179742 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk score based on five independent predictors of no-reflow (NRF)
Number of subjects: 1254
Study 35179742 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent predictors of NRF: age ≥ 65 years (OR: 2.473, p < 0.01), heart rate ≥ 89 bpm (OR: 1.622, p < 0.05), Killip class ≥ II (OR: 1.914, p < 0.01), total ischemic time ≥ 268 min (OR: 2.652, p < 0.01), thrombus burden G≥4 (OR: 8.351, p < 0.01)
Number of subjects: 1254
Study 32897568 — intervention group
Group type: EXPERIMENTAL
Intervention: ECC
Number of subjects: 30
Study 32897568 — intervention group
Group type: EXPERIMENTAL
Intervention: CON-ECC
Number of subjects: 30
Study 32897568 — intervention group
Group type: COMPARATOR
Intervention: CTRL
Number of subjects: 30
Study 36451454 — intervention group
Group type: EXPERIMENTAL
Intervention: EPIAO®
Number of subjects: 200
Study 36451454 — intervention group
Group type: COMPARATOR
Intervention: EPREX®
Number of subjects: 200
Study 34009291 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative systemic therapy (CAPOX, FOLFOX, or FOLFIRI)
Number of subjects: 79
Study 34009291 — intervention group
Group type: COMPARATOR
Intervention: CRS‐HIPEC alone (control)
Number of subjects: 79
Study 32790108 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 3620
Study 32790108 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 3620
Study 35353246 — intervention group
Group type: EXPERIMENTAL
Intervention: Urethral mid‐point Foley catheter measurement (FCM)
Number of subjects: 44
Study 35353246 — intervention group
Group type: COMPARATOR
Intervention: Usual surgical care (no Foley catheter measurement, no‐FCM)
Number of subjects: 44
Study 33589320 — intervention group
Group type: EXPERIMENTAL
Intervention: Wholegrain enriched diet
Number of subjects: 54
Study 33589320 — intervention group
Group type: COMPARATOR
Intervention: Refined-wheat cereals diet (control diet)
Number of subjects: 54
Study 34414835 — intervention group
Group type: EXPERIMENTAL
Intervention: Zip‐stitch clips
Number of subjects: 27
Study 34414835 — intervention group
Group type: COMPARATOR
Intervention: VICRYL sutures
Number of subjects: 27
Study 33612600 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive BGL Measurement Optical Device (NI-BGL-MOD)
Number of subjects: 110
Study 33612600 — intervention group
Group type: COMPARATOR
Intervention: Reference standard: venipuncture spectrophotometry
Number of subjects: 110
Study 35219336 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Care Model (CCM) using a smartphone application
Number of subjects: 72
Study 35219336 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 72
Study 34146140 — intervention group
Group type: EXPERIMENTAL
Intervention: Image-guided interventional procedures around the hip
Number of subjects: 53
Study 34146140 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert consensus
Number of subjects: 53
Study 34146140 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence level for statements
Number of subjects: 53
Study 34146140 — intervention group
Group type: EXPERIMENTAL
Intervention: Consensus strength
Number of subjects: 53
Study 32761844 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 342
Study 32761844 — intervention group
Group type: COMPARATOR
Intervention: Relaxation control
Number of subjects: 342
Study 36001429 — intervention group
Group type: COMPARATOR
Intervention: Alcohol administration (intravenous clamping procedure to achieve a breath alcohol concentration of 0.05% maintained over 3 hours)
Number of subjects: 70
Study 36001429 — intervention group
Group type: COMPARATOR
Intervention: Self-administered alcohol (intravenous)
Number of subjects: 70
Study 34463420 — intervention group
Group type: COMPARATOR
Intervention: Dulaglutide 1.5 mg
Number of subjects: 0
Study 34463420 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulaglutide 3.0 mg
Number of subjects: 0
Study 34463420 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulaglutide 4.5 mg
Number of subjects: 0
Study 34463420 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulaglutide 3.0 mg and 4.5 mg
Number of subjects: 0
Study 35481935 — intervention group
Group type: EXPERIMENTAL
Intervention: Portable air cleaners (PACs) with HEPA filters
Number of subjects: 17
Study 35481935 — intervention group
Group type: COMPARATOR
Intervention: Sham (filter removed)
Number of subjects: 17
Study 33857011 — intervention group
Group type: EXPERIMENTAL
Intervention: Withings ScanWatch
Number of subjects: 14
Study 37097308 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerehabilitation exercise program (clinical Pilates-based exercises via YouTube, performed twice daily for 8 weeks)
Number of subjects: 46
Study 37097308 — intervention group
Group type: COMPARATOR
Intervention: Control group (home exercise program using printed brochures for 8 weeks)
Number of subjects: 46
Study 34468410 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated microneedling
Number of subjects: 30
Study 34468410 — intervention group
Group type: COMPARATOR
Intervention: Fractional CO2 laser
Number of subjects: 30
Study 32352320 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab plus bevacizumab
Number of subjects: 0
Study 32352320 — intervention group
Group type: COMPARATOR
Intervention: Active surveillance
Number of subjects: 0
Study 35373340 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgingival air-polishing therapy with erythritol powder (EPAP) as adjunct to conventional subgingival instrumentation
Number of subjects: 21
Study 35373340 — intervention group
Group type: COMPARATOR
Intervention: Conventional subgingival instrumentation alone
Number of subjects: 21
Study 33637231 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 500
Study 33637231 — intervention group
Group type: EXPERIMENTAL
Intervention: Hearing aids
Number of subjects: 500
Study 33637231 — intervention group
Group type: EXPERIMENTAL
Intervention: Sound stimulation
Number of subjects: 500
Study 33637231 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured counseling
Number of subjects: 500
Study 33637231 — intervention group
Group type: COMPARATOR
Intervention: Combination treatments
Number of subjects: 500
Study 32866624 — intervention group
Group type: EXPERIMENTAL
Intervention: CoMut (coexisting mutations)
Number of subjects: 542
Study 34672254 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation of terazosin hydrochloride (2 mg)
Number of subjects: 48
Study 34672254 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation of terazosin hydrochloride (2 mg)
Number of subjects: 48
Study 34672254 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting condition
Number of subjects: 48
Study 34672254 — intervention group
Group type: EXPERIMENTAL
Intervention: Fed condition
Number of subjects: 48
Study 32992785 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + VD 25,000 IU/week
Number of subjects: 27
Study 32992785 — intervention group
Group type: COMPARATOR
Intervention: SRP + placebo
Number of subjects: 27
Study 36113187 — intervention group
Group type: EXPERIMENTAL
Intervention: Fully no-touch technique
Number of subjects: 0
Study 36113187 — intervention group
Group type: COMPARATOR
Intervention: Conventional cephalic vein inflation
Number of subjects: 0
Study 32096586 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics nomogram based on multiparametric MRI (mpMRI) features including T1 WI, FS-T2 WI, CE, DWI, and ADC maps.
Number of subjects: 233
Study 32096586 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics nomogram based on multiparametric MRI (mpMRI) features.
Number of subjects: 233
Study 32096586 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics nomogram incorporating MRI-reported LN status and FIGO stage.
Number of subjects: 233
Study 32096586 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics nomogram.
Number of subjects: 233
Study 33430189 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component lifestyle intervention against cognitive decline
Number of subjects: 1030
Study 32498367 — intervention group
Group type: EXPERIMENTAL
Intervention: National Exercise Referral Scheme (NERS)
Number of subjects: 83598
Study 34069308 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooking classes (6 weeks, once per week)
Number of subjects: 0
Study 34069308 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal kit provision (6 weekly kits, 3 meals per kit)
Number of subjects: 0
Study 34069308 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 0
Study 32871473 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus
Number of subjects: 67
Study 32871473 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 67
Study 34142896 — intervention group
Group type: EXPERIMENTAL
Intervention: Trunk exercise program
Number of subjects: 28
Study 34142896 — intervention group
Group type: COMPARATOR
Intervention: Upper and lower limb exercises (Control)
Number of subjects: 28
Study 33226524 — intervention group
Group type: EXPERIMENTAL
Intervention: darolutamide 600 mg twice daily
Number of subjects: 95
Study 33226524 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 95
Study 32967616 — intervention group
Group type: EXPERIMENTAL
Intervention: Underwater endoscopic mucosal resection (UEMR)
Number of subjects: 142
Study 32967616 — intervention group
Group type: COMPARATOR
Intervention: Conventional endoscopic mucosal resection (CEMR)
Number of subjects: 142
Study 36243580 — intervention group
Group type: EXPERIMENTAL
Intervention: HYR-PB21 300 mg
Number of subjects: 72
Study 36243580 — intervention group
Group type: EXPERIMENTAL
Intervention: HYR-PB21 150 mg
Number of subjects: 72
Study 36243580 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine HCl 75 mg
Number of subjects: 72
Study 33123730 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis sativa oil (1g of cannabis in 10g of olive oil) for 4 weeks
Number of subjects: 17
Study 32351642 — intervention group
Group type: EXPERIMENTAL
Intervention: Empathy condition (SAR robot programmed with empathy)
Number of subjects: 31
Study 32351642 — intervention group
Group type: EXPERIMENTAL
Intervention: Distraction condition (SAR robot programmed with distraction)
Number of subjects: 31
Study 32351642 — intervention group
Group type: COMPARATOR
Intervention: No robot (control group)
Number of subjects: 31
Study 35799673 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression model
Number of subjects: 200
Study 35799673 — intervention group
Group type: EXPERIMENTAL
Intervention: XGBoost algorithm model
Number of subjects: 200
Study 33822406 — intervention group
Group type: EXPERIMENTAL
Intervention: CT‐P17 AI (40 mg/0.4 mL)
Number of subjects: 193
Study 33822406 — intervention group
Group type: COMPARATOR
Intervention: CT‐P17 PFS (40 mg/0.4 mL)
Number of subjects: 193
Study 33822406 — intervention group
Group type: EXPERIMENTAL
Intervention: CT‐P17 AI and CT‐P17 PFS
Number of subjects: 193
Study 33730255 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior HCV test
Number of subjects: 399
Study 33730255 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior diagnosis of HCV
Number of subjects: 399
Study 33730255 — intervention group
Group type: EXPERIMENTAL
Intervention: Received treatment for HCV
Number of subjects: 399
Study 33730255 — intervention group
Group type: EXPERIMENTAL
Intervention: Cured of HCV
Number of subjects: 399
Study 33345474 — intervention group
Group type: EXPERIMENTAL
Intervention: 16G puncture needle
Number of subjects: 142
Study 33345474 — intervention group
Group type: COMPARATOR
Intervention: 18G puncture needle
Number of subjects: 142
Study 36197287 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprepitant
Number of subjects: 130
Study 36197287 — intervention group
Group type: COMPARATOR
Intervention: Desloratadine
Number of subjects: 130
Study 33524293 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaximin (600 mg twice daily)
Number of subjects: 197
Study 33524293 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study 32869564 — intervention group
Group type: EXPERIMENTAL
Intervention: BNO 1045 (Canephron®N)
Number of subjects: 657
Study 32869564 — intervention group
Group type: COMPARATOR
Intervention: FT (fosfomycin trometamol)
Number of subjects: 657
Study 32291360 — intervention group
Group type: EXPERIMENTAL
Intervention: SCT-based anti-bullying intervention
Number of subjects: 280
Study 32291360 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 280
Study 35612469 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback video game with mirroring visualizations
Number of subjects: 67
Study 35612469 — intervention group
Group type: COMPARATOR
Intervention: Biofeedback video game without mirroring visualizations
Number of subjects: 67
Study 33600092 — intervention group
Group type: EXPERIMENTAL
Intervention: CPC/GK2/TXA mouthwash used 3x/day for 7 to 10 days postoperatively
Number of subjects: 20
Study 33600092 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouthwash
Number of subjects: 20
Study 33600092 — intervention group
Group type: EXPERIMENTAL
Intervention: CPC/GK2/TXA mouthwash
Number of subjects: 20
Study 33136048 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular overdentures retained by implants with 2 Locator attachments
Number of subjects: 20
Study 33136048 — intervention group
Group type: COMPARATOR
Intervention: Conventional dentures
Number of subjects: 20
Study 616386675 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MedDiet)
Number of subjects: 166
Study 616386675 — intervention group
Group type: COMPARATOR
Intervention: Habitual diet (HabDiet)
Number of subjects: 166
Study 34846603 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy-reduced Mediterranean diet (MedDiet) intervention
Number of subjects: 2985
Study 33186998 — intervention group
Group type: EXPERIMENTAL
Intervention: Spaced learning concept
Number of subjects: 34
Study 33186998 — intervention group
Group type: COMPARATOR
Intervention: Conventional methods
Number of subjects: 34
Study 33262577 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram oxalate 20 mg tablets (generic)
Number of subjects: 24
Study 33262577 — intervention group
Group type: COMPARATOR
Intervention: Lexapro® (brand name)
Number of subjects: 24
Study 616571495 — intervention group
Group type: EXPERIMENTAL
Intervention: Acoustically isolated room
Number of subjects: 24
Study 616571495 — intervention group
Group type: COMPARATOR
Intervention: Domestic environment
Number of subjects: 24
Study 616571495 — intervention group
Group type: COMPARATOR
Intervention: Sleep lab
Number of subjects: 24
Study 33548159 — intervention group
Group type: EXPERIMENTAL
Intervention: Irinotecan (IRI)
Number of subjects: 487
Study 33548159 — intervention group
Group type: COMPARATOR
Intervention: Oxaliplatin (OX)
Number of subjects: 487
Study 35247214 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma exchange therapy (PE)
Number of subjects: 20
Study 35247214 — intervention group
Group type: COMPARATOR
Intervention: Historical control (no plasma exchange)
Number of subjects: 20
Study 34031262 — intervention group
Group type: EXPERIMENTAL
Intervention: COBRA Slim (MTX 15mg with step-down glucocorticoid scheme)
Number of subjects: 90
Study 34031262 — intervention group
Group type: COMPARATOR
Intervention: Tight-Step-Up (TSU) (MTX without oral GCs)
Number of subjects: 90
Study 34031262 — intervention group
Group type: COMPARATOR
Intervention: Comparison of total NSAID and analgesic use
Number of subjects: 90
Study 34031262 — intervention group
Group type: COMPARATOR
Intervention: Comparison of chronic NSAID and analgesic use
Number of subjects: 90
Study 34031262 — intervention group
Group type: COMPARATOR
Intervention: Comparison of daily chronic NSAID use
Number of subjects: 90
Study 33219150 — intervention group
Group type: EXPERIMENTAL
Intervention: DIANES score (based on IA diameter, indication, parent artery diameter ratio, neck ratio, side-branch artery, and sex)
Number of subjects: 146
Study 33219150 — intervention group
Group type: EXPERIMENTAL
Intervention: DIANES score
Number of subjects: 146
Study 32918519 — intervention group
Group type: EXPERIMENTAL
Intervention: FACE Advance Care Planning intervention
Number of subjects: 126
Study 33026143 — intervention group
Group type: EXPERIMENTAL
Intervention: efpeglenatide (4 mg or 6 mg)
Number of subjects: 4076
Study 33026143 — intervention group
Group type: COMPARATOR
Intervention: masked placebo
Number of subjects: 4076
Study 33189178 — intervention group
Group type: EXPERIMENTAL
Intervention: Selinexor (100 mg once per week), bortezomib (1.3 mg/m2 once per week), and dexamethasone (20 mg twice per week)
Number of subjects: 402
Study 33189178 — intervention group
Group type: COMPARATOR
Intervention: Bortezomib (1.3 mg/m2 twice per week for the first 24 weeks and once per week thereafter) and dexamethasone (20 mg four times per week for the first 24 weeks and twice per week thereafter)
Number of subjects: 402
Study 33189178 — intervention group
Group type: EXPERIMENTAL
Intervention: Selinexor, bortezomib, and dexamethasone
Number of subjects: 402
Study 33189178 — intervention group
Group type: COMPARATOR
Intervention: Bortezomib and dexamethasone
Number of subjects: 402
Study 33338442 — intervention group
Group type: EXPERIMENTAL
Intervention: nab-paclitaxel plus gemcitabine
Number of subjects: 130
Study 33338442 — intervention group
Group type: COMPARATOR
Intervention: sequential FOLFIRINOX
Number of subjects: 130
Study 33964325 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 months of androgen deprivation therapy (ADT) plus high-dose radiotherapy (HRT)
Number of subjects: 355
Study 33964325 — intervention group
Group type: COMPARATOR
Intervention: 24 months of ADT following 4 months of ADT plus HRT
Number of subjects: 355
Study 33964325 — intervention group
Group type: EXPERIMENTAL
Intervention: Time to testosterone recovery after ADT
Number of subjects: 355
Study 33427180 — intervention group
Group type: EXPERIMENTAL
Intervention: Public speaking task (Trier Social Stress Test - modified for children, TSST-M) with parent (N = 59)
Number of subjects: 180
Study 33427180 — intervention group
Group type: EXPERIMENTAL
Intervention: Public speaking task (Trier Social Stress Test - modified for children, TSST-M) alone (N = 60)
Number of subjects: 180
Study 33427180 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no TSST-M, N = 61)
Number of subjects: 180
Study 34561086 — intervention group
Group type: EXPERIMENTAL
Intervention: saline
Number of subjects: 201
Study 34561086 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% hydrogen peroxide
Number of subjects: 201
Study 34561086 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine
Number of subjects: 201
Study 34561086 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% povidone-iodine
Number of subjects: 201
Study 33485371 — intervention group
Group type: EXPERIMENTAL
Intervention: VTS Glove (vibrotactile stimulation)
Number of subjects: 16
Study 33485371 — intervention group
Group type: COMPARATOR
Intervention: Control (identical glove with vibration disabled)
Number of subjects: 16
Study 32294560 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 7% and Tetracaine 7% self-occlusive cream (LT-C), applied 1 hour before MAL-cPDT session.
Number of subjects: 50
Study 32294560 — intervention group
Group type: COMPARATOR
Intervention: Vehicle cream (control group).
Number of subjects: 50
Study 32294560 — intervention group
Group type: COMPARATOR
Intervention: Comparison of LT-C vs Vehicle cream.
Number of subjects: 50
Study 36371994 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab-plus-chemotherapy group (n = 36)
Number of subjects: 123
Study 36371994 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab-monotherapy group (n = 52)
Number of subjects: 123
Study 36371994 — intervention group
Group type: COMPARATOR
Intervention: Non-trastuzumab group (n = 32)
Number of subjects: 123
Study 36371994 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 123
Study 34185752 — intervention group
Group type: COMPARATOR
Intervention: Routine in-campus education of health knowledge related to the epidemic
Number of subjects: 160
Study 32172488 — intervention group
Group type: EXPERIMENTAL
Intervention: YLB113
Number of subjects: 52
Study 32172488 — intervention group
Group type: COMPARATOR
Intervention: Etanercept RP (Enbrel)
Number of subjects: 52
Study 32172488 — intervention group
Group type: EXPERIMENTAL
Intervention: YLB113 and Etanercept RP
Number of subjects: 52
Study 33730409 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial middle turbinate resection
Number of subjects: 38
Study 33730409 — intervention group
Group type: COMPARATOR
Intervention: Bolgerization of the middle turbinate
Number of subjects: 38
Study 32183768 — intervention group
Group type: EXPERIMENTAL
Intervention: Eurythmy therapy (EYT)
Number of subjects: 550
Study 32183768 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 550